Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
[Cerebrospinal fluid diagnostics in multiple sclerosis].
Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.
Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Children and Their Long-Term Follow-Up.
What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
Validation of the Oxford Participation and Activities Questionnaire.
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratio.
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease.
Internet-Supported Physical Exercise Training for Persons with Multiple Sclerosis-A Randomised, Controlled Study.
Mutations in MYT1, encoding the myelin transcription factor 1, are a rare cause of OAVS.
JCV serology in time: 3 years of follow-up.
Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
The role of autophagy in the pathogenesis of systemic lupus erythematosus.
Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques.
Defining secondary progressive multiple sclerosis.
Perspectives on Safety and Efficacy-The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis.
MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts.
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Metabolic Patterns in Chronic MS Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using Two-Dimensional MR Spectroscopic Imaging.
A Risk Score for Predicting Multiple Sclerosis.
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery.
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Pages
« first
‹ previous
…
772
773
774
775
776
777
778
779
780
…
next ›
last »